Dietary Supplement of Curcumin in Subjects With Active Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta 1a

NCT01514370 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: IFN beta 1a 44 mcg TIW
DRUG: Curcumin
DRUG: Placebo

Sponsor

Merck KGaA, Darmstadt, Germany

Collaborators

[object Object]